Viewing Study NCT03789968

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 5:39 PM

Ignite Modification Date: 2025-12-24 @ 5:39 PM

Study NCT ID: NCT03789968

Status: COMPLETED

Last Update Posted: 2020-10-08

First Post: 2018-12-26

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: The Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients

Sponsor: Thomas Jefferson University

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module